European regulators Struggle with Globalisation of Clinical Trials - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

European regulators Struggle with Globalisation of Clinical Trials
The globalisation of clinical trials is putting pressure on the European Medicines Agency.


Pharmaceutical Technology Europe
Volume 24, Issue 6

8. I. Hall, "Pharma firms hit back at C4's drugs documentary" (PR Week, 2003). http://www.prweek.com/, accessed 30 April 2012.

9. N. Lakhani "From tragedy to travesty: Drugs tested on survivors of Bhopal" (The Independent, 2011). http://www.independent.co.uk/, accessed 30 April 2012.

10. A. Buncome, "Delhi to examine weak regulation' of clinical trials" (The Independent, 2011). http://www.independent.co.uk/, accessed 30 April 2012.

11. N. Lakhani, "Europe targets drug firms over unethical practices" (The Independent, 2011). http://www.independent.co.uk/. accessed 30 April 2012.

12 Wemos, "The Globalization of Clinical Trials: Testimonies from Human Subjects" (Wemos website, 2010). http://www.wemos.nl/, accessed 30 April 2012.

13 EMA, "Towards a robust global framework for conduct and oversight of clinical trials" (EMA website, 2012). http://www.ema.europa.eu/, accessed 30 April 2012.

14. EMA, "International collaboration on good manufacturing practice inspections expanded" (EMA website, 2012). http://www.ema.europa.eu/, accessed 30 April 2012.


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
29%
Attracting a skilled workforce
27%
Obtaining/maintaining adequate financing
13%
Regulatory compliance
31%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Report: Pfizer Makes $101 Billion Offer to AstraZeneca
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Source: Pharmaceutical Technology Europe,
Click here